TransMedics Group, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 10 →Insiders1 insider bought $1.0M in 1 open-market buy. 7 insiders sold $4.9M, 1 of 12 sales on a 10b5-1 plan.→HoldersBlackRock 16.2%FMR 14.8%Vanguard Portfolio 5.6%→PeersClosest companies: LUNG, BVS, INGN→
From the filings
Figures
- Revenue
- $668.5Mlast 12 months
- Net income
- $151.7Mlast 12 months
- Operating cash flow
- $220.2Mlast 12 months
- Cash and equivalents
- $491.1Mat the last balance sheet
- Total debt
- $20.0Mat the last balance sheet
- Shares outstanding
- 34.6M shareson issue